Phase 2/3Completed
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza
- Sponsor
- Romark Laboratories L.C. (Industry)
- Enrollment
- 624 enrolled
- Conditions
- Influenza
- Interventions
- Nitazoxanide; Nitazoxanide; Placebo
- Ages
- children, adults, older adults
- Registry
- NCT01227421
Full record on ClinicalTrials.gov
From the registry
This is a randomized clinical trial designed to evaluate the safety/efficacy of two dosing regimens of oral nitazoxanide compared to placebo in the treatment of acute uncomplicated influenza in adults and adolescents. The investigators hypothesize that treatment with Nitazoxanide will reduce the duration of symptoms in patients with confirmed influenza infection. Secondarily, the investigators hypothesize that treatment with nitazoxanide will reduce the complications of influenza, severity of symptoms, time lost from work, time to return to normal daily activities.
Primary outcomes
- Time to Resolution of All Clinical Symptoms of Influenza as Reported by the Subjects
History
Last registry update
Results first posted
Study completion
Primary completion
Started
Registered